Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor
11 June 2024 - 4:30AM
AllPennyStocks.com
CAR T-cell therapy has seen significant growth and much promise,
as it provides targeted and personalized treatment for patients
with certain types of cancer, particularly those that have
not...
To read the full story on AllPennyStocks.com, click
here.
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Mar 2025 to Apr 2025
SOHM (PK) (USOTC:SHMN)
Historical Stock Chart
From Apr 2024 to Apr 2025
